(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Neutrophil Elastase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Neutrophil Elastase Inhibitors. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Bronchiectasis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Bronchiectasis. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Nasopharyngitis (Common Cold)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Lysine Specific Demethylase 1 (LSD-1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Lysine Specific Demethylase 1 (LSD-1) Inhibitors. The Publisher's Report...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Interleukin-13 (IL-13) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-13 (IL-13) Inhibitors. The Publisher's Report covers the product profiles...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "HIV-2 Protease (HIV-2 PR) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the HIV-2 Protease (HIV-2 PR) Inhibitors. The Publisher's Report covers the product...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Glutamate Receptor Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Glutamate Receptor Antagonists. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, January 28, 2017 ) Process Analyzers are engineering precision equipment used for incessant monitoring of parameters such as gas and liquid content during the manufacturing process. It has redefined the way by which companies carry out their production and improve the overall...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Uterine Fibroids-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Uterine Fibroids. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors. The Publisher's...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Pain Management Drugs and Devices market is expected to grow from $39.48 billion in 2015 to reach $58.2 billion by 2022 with a CAGR of 5.7%. Growing various pain disorders coupled with increasing global geriatric people is...
(PharmaNewsWire.Com, January 27, 2017 ) According to Publisher, the Global Home Healthcare market is expected to grow from $229.83 billion in 2015 to reach $449.56 billion by 2022 with a CAGR of 10.1%. Growing global geriatric population, raising health diseases, and cost efficiency of home healthcare...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Systemic Mastocytosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Systemic Mastocytosis. The DelveInsight'sReport covers the product profiles in various stages...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: